The Trump administration’s data center push is spurring concerns about energy prices and environmental impacts. The administration has embraced data centers, which house the computers and ...

Apple (AAPL) bringing its Apple Intelligence features to China may be getting closer after a new feedback form recently popped up on the tech giant's website, MacRumors reported. The feedback form ...

In recent months, the Trump administration has opened a deregulatory floodgate in the name of building more data centers. Among other things, this has involved ordering rollbacks of clean water ...

The newly appointed president of the board that regulates Alabama’s utilities is calling for limits on how the data center industry uses the state’s power resources. Alabama Public Service Commission ...

Alphabet's Google is investing $40 billion to build new data centers in two Texas counties. The announcement, made Friday, said one of the new data centers will be in Armstrong County, in the Texas ...

At least 16 data center projects, worth a combined $64 billion, have been blocked or delayed as local opposition mounts to the developments, according to a new study. Research collected by Data Center ...

Pseudo planche push ups (PPPUs) are one of the many push up variations you can learn, but what makes them unique is that they're very demanding on the shoulders and wrists, plus even incorporates ...

WASHINGTON — Firefly Aerospace is sharpening its focus on U.S. missile defense and national security work, underscoring that shift during its latest earnings call as it integrates its newly acquired ...

Artificial intelligence company Anthropic announced a $50 billion investment in computing infrastructure on Wednesday that will include new data centers in Texas and New York. Microsoft also on ...

Portland man arrested for alleged sexual abuse of homeless 15-year-old girl A Portland man, Nicholas Tull, has been arrested following allegations of sexual abuse involving a 15-year-old girl. WW: ...

Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market served by Alnylam Pharmaceuticals, BridgeBio and Pfizer. The phase 2 trial compared two doses of ...